Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration of the naive pluripotency gene network with the response to GSK3 inhibition by Tcf7l1-driven enhancer decommissioning.

Stem cell reports·2026
Same author

Activation-induced SLC7A1 expression enhances T cell sensitivity to cGAMP-mediated STING signaling.

Cell reports·2026
Same author

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

bioRxiv : the preprint server for biology·2026
Same author

Crossing borders with parenteral nutrition: A pediatric case of international travel on home parenteral nutrition.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same author

Osteogenic Potential of 3D Bioprinted Collagen Scaffolds Enriched with Bone Marrow Stromal Cells, BMP-2, and Hydroxyapatite in a Rabbit Calvarial Defect Model.

Journal of functional biomaterials·2026
Same author

Molecular pixelation of the CAR T cell surface proteome.

bioRxiv : the preprint server for biology·2026
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.1K

Ultra-large targeted DNA integrations in primary human cells.

Courtney Kernick1, Lauren Chow2,3,4, Mikail Alejandro5,6

  • 1Department of Pathology, Stanford University, Stanford, CA, USA.

Biorxiv : the Preprint Server for Biology
|April 17, 2026
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel non-viral method for ultra-large DNA integrations (>10kb) into human cells, overcoming previous size limitations for genetic engineering and cell therapies.

More Related Videos

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.3K
Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

4.7K

Related Experiment Videos

Last Updated: Apr 18, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.1K
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.3K
Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

4.7K

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Cellular Engineering

Background:

  • Current gene editing methods like AAV and lentiviral vectors face limitations in DNA integration size, with efficiency dropping significantly beyond 5kb.
  • This constraint hinders the development of advanced genetic therapies and research requiring large DNA payloads.

Purpose of the Study:

  • To identify and optimize non-viral methods for efficient integration of large DNA sequences (>5kb) into human cells.
  • To enable the development of next-generation cellular therapies and accelerate genetic research.

Main Methods:

  • Systematic evaluation of circular single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) as non-viral delivery templates.
  • Optimization of delivery using helper plasmids, mRNA-encoded nucleases, and sequence design.
  • Testing integration efficiency in primary human T cells and induced pluripotent stem cells (iPSCs).

Main Results:

  • Circular DNA templates demonstrated capability for >5kb integrations, surpassing existing non-viral methods.
  • Optimized delivery strategies significantly improved efficiency and cell viability for large DNA integrations.
  • Achieved ultra-large DNA integrations (up to 10kb) at >20% efficiency in human T cells and >60% efficiency in iPSCs.
  • Clinically manufactured T cells with ultra-large integrations showed functionality in vitro and in vivo.

Conclusions:

  • Circular DNA templates, optimized delivery, and sequence design enable efficient ultra-large DNA integrations (>10kb) in human cells.
  • This breakthrough provides a scalable platform for genetic engineering and the development of advanced cellular therapies.
  • The findings offer crucial insights for both basic genetic research and clinical applications.